JP2020523408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523408A5 JP2020523408A5 JP2020517619A JP2020517619A JP2020523408A5 JP 2020523408 A5 JP2020523408 A5 JP 2020523408A5 JP 2020517619 A JP2020517619 A JP 2020517619A JP 2020517619 A JP2020517619 A JP 2020517619A JP 2020523408 A5 JP2020523408 A5 JP 2020523408A5
- Authority
- JP
- Japan
- Prior art keywords
- cardiovascular
- disease
- pharmaceutical composition
- canagliflozin
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023077544A JP2023113644A (ja) | 2017-06-12 | 2023-05-10 | ２型糖尿病の患者における心血管イベントの低減又は予防方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518547P | 2017-06-12 | 2017-06-12 | |
| US62/518,547 | 2017-06-12 | ||
| PCT/IB2018/054208 WO2018229630A1 (en) | 2017-06-12 | 2018-06-11 | Method for reducing or preventing cardiovascular events in patients with type ii diabetes mellitus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077544A Division JP2023113644A (ja) | 2017-06-12 | 2023-05-10 | ２型糖尿病の患者における心血管イベントの低減又は予防方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020523408A JP2020523408A (ja) | 2020-08-06 |
| JP2020523408A5 true JP2020523408A5 (enExample) | 2022-09-27 |
Family
ID=62916717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517619A Pending JP2020523408A (ja) | 2017-06-12 | 2018-06-11 | ２型糖尿病の患者における心血管イベントの低減又は予防方法 |
| JP2023077544A Withdrawn JP2023113644A (ja) | 2017-06-12 | 2023-05-10 | ２型糖尿病の患者における心血管イベントの低減又は予防方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077544A Withdrawn JP2023113644A (ja) | 2017-06-12 | 2023-05-10 | ２型糖尿病の患者における心血管イベントの低減又は予防方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180353470A1 (enExample) |
| EP (1) | EP3638250A1 (enExample) |
| JP (2) | JP2020523408A (enExample) |
| KR (1) | KR20200014406A (enExample) |
| CN (1) | CN110740735A (enExample) |
| AU (1) | AU2018283781B2 (enExample) |
| BR (1) | BR112019026120A2 (enExample) |
| CA (1) | CA3066874A1 (enExample) |
| CO (1) | CO2019013940A2 (enExample) |
| EA (1) | EA202090028A1 (enExample) |
| IL (1) | IL271100A (enExample) |
| MX (1) | MX2019014988A (enExample) |
| TW (1) | TWI835735B (enExample) |
| UA (1) | UA127987C2 (enExample) |
| WO (1) | WO2018229630A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI827184B (zh) * | 2021-08-03 | 2023-12-21 | 國立政治大學 | 第2型糖尿病併發症的風險評估系統與方法 |
| CN117085009B (zh) * | 2023-10-20 | 2024-01-30 | 首都医科大学附属北京天坛医院 | 卡格列净对急性缺血性卒中的治疗作用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104109155A (zh) | 2003-08-01 | 2014-10-22 | 田边三菱制药株式会社 | 新颖化合物 |
| UY30730A1 (es) | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
| ES2455124T5 (es) * | 2010-05-05 | 2018-05-08 | Zora Biosciences Oy | Biomarcadores lipidómicos para la aterosclerosis y afección cardíaca |
| JP5596799B2 (ja) * | 2010-05-11 | 2014-09-24 | 田辺三菱製薬株式会社 | カナグリフロジン含有錠剤 |
| US20160000816A1 (en) * | 2013-04-05 | 2016-01-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812016A1 (en) * | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CN105939728A (zh) * | 2014-01-31 | 2016-09-14 | 詹森药业有限公司 | 用于治疗和预防肾病和脂肪肝病的方法 |
| US20170071970A1 (en) * | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
-
2018
- 2018-06-08 TW TW107119774A patent/TWI835735B/zh not_active IP Right Cessation
- 2018-06-11 JP JP2020517619A patent/JP2020523408A/ja active Pending
- 2018-06-11 BR BR112019026120-6A patent/BR112019026120A2/pt not_active Application Discontinuation
- 2018-06-11 EA EA202090028A patent/EA202090028A1/ru unknown
- 2018-06-11 CA CA3066874A patent/CA3066874A1/en active Pending
- 2018-06-11 US US16/004,607 patent/US20180353470A1/en not_active Abandoned
- 2018-06-11 MX MX2019014988A patent/MX2019014988A/es unknown
- 2018-06-11 UA UAA202000168A patent/UA127987C2/uk unknown
- 2018-06-11 KR KR1020207000103A patent/KR20200014406A/ko not_active Ceased
- 2018-06-11 WO PCT/IB2018/054208 patent/WO2018229630A1/en not_active Ceased
- 2018-06-11 EP EP18740894.3A patent/EP3638250A1/en not_active Withdrawn
- 2018-06-11 AU AU2018283781A patent/AU2018283781B2/en not_active Ceased
- 2018-06-11 CN CN201880039211.2A patent/CN110740735A/zh active Pending
-
2019
- 2019-12-02 IL IL271100A patent/IL271100A/en unknown
- 2019-12-11 CO CONC2019/0013940A patent/CO2019013940A2/es unknown
-
2020
- 2020-09-15 US US17/021,370 patent/US20210000792A1/en not_active Abandoned
-
2023
- 2023-05-10 JP JP2023077544A patent/JP2023113644A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7454531B2 (ja) | エンパグリフロジンを含む医薬組成物及びその使用 | |
| Kimura et al. | JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome | |
| JP7020756B2 (ja) | 対象の心血管イベントのリスクを低減する方法 | |
| 2005 Writing Committee Members et al. | 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation | |
| Vinik et al. | Prevention of the complications of diabetes | |
| Sakai et al. | Effects of sodium-glucose cotransporter 2 inhibitor on vascular endothelial and diastolic function in heart failure with preserved ejection fraction―novel prospective cohort study― | |
| AU2025202801A9 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
| Lundwall et al. | Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial | |
| CN114980973A (zh) | 降低心房纤颤和/或心房扑动受试者心血管事件风险的方法 | |
| TW202108134A (zh) | 利用達格列淨治療射血分率降低的心臟衰竭之方法 | |
| JP2023113644A (ja) | ２型糖尿病の患者における心血管イベントの低減又は予防方法 | |
| AU2013241776B2 (en) | Basal insulin therapy | |
| Maung et al. | Hypokalaemic rhabdomyolysis as initial presentation of primary aldosteronism | |
| Azeez | Present State and Perspectives of Type 2 Diabetes Management | |
| HK40021204A (en) | Method for reducing or preventing cardiovascular events in patients with type ii diabetes mellitus | |
| O’Donnell et al. | Cardiovascular Complications of Minoxidil Toxicosis in Two Dogs | |
| EP4477224A1 (en) | Pharmaceutical composition comprising allopurinol, febuxostat, or a pharmaceutically acceptable salt thereof for preventing or treating cardiovascular disease of subject having high blood uric acid level | |
| Al-Harbi | An open-label, uncontrolled study to evaluate the effect of verapamil on glycaemic control in type 2 diabetes mellitus patients with hypertension | |
| Faixová et al. | THE USE OF SINGLE-PILL COMBINATION THERAPY IN ARTERIAL HYPERTENSION: CASE STUDIES. | |
| Afshinnia et al. | Approach to Chronic Kidney Disease in the Diabetic Patient | |
| HK40079514B (en) | Methods of reducing the risk of cardiovascular events in a subject | |
| HK40079514A (en) | Methods of reducing the risk of cardiovascular events in a subject | |
| CA3083432A1 (en) | Method of providing celiprolol therapy to a patient |